🩸 Sulforaphane Prevents Cardiovascular Diseases through Nrf2 Activation

This study comprehensively analyzes how sulforaphane prevents cardiovascular diseases (CVDs) through the activation of the Nrf2 signaling pathway.

Last updated on 2025.10.08 (Posted on 2025.04.22)

  • Paper Title: Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation
  • Journal: Oxidative Medicine and Cellular Longevity, 2015

🧬 Mechanisms of Action

  • Activation of the Nrf2–Keap1–ARE Pathway:
    Sulforaphane inhibits Nrf2 degradation and promotes its nuclear translocation, inducing antioxidant genes such as HO-1, NQO1, and GST.
  • Involvement of MAPK/PI3K Pathways:
    Activation of ERK, JNK, p38, and PI3K/AKT enhances Nrf2 phosphorylation and stability.
  • Long-Term Protection:
    Antioxidant gene expression remains elevated for several days after sulforaphane intake, providing sustained vascular protection.

💡 Summary of Protective Mechanisms

ConditionProtective Mechanism
HypertensionReduces vascular oxidative stress and improves blood pressure.
AtherosclerosisSuppresses inflammation and decreases VCAM-1/ICAM-1 expression.
Ischemia–Reperfusion InjuryMinimizes myocardial damage and cell death.
Diabetic ComplicationsProtects vascular and renal tissues; reduces inflammation.
ThrombosisInhibits platelet aggregation and supports anticoagulant activity.
; ; ; ;

Tags